Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in Newly Diagnosed Grade 3 Meningioma
NCT05940493Phase 2Recruiting
- Sponsor
- Ivy Brain Tumor Center
- Start
- Mar 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in meningioma, sponsored by Ivy Brain Tumor Center. Started Mar 2025; status: recruiting.
02
Drugs
abemaciclib
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT05940493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05940493.